Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

ClinicalTrials.gov ID: NCT00872898

Public ClinicalTrials.gov record NCT00872898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the safety and efficacy of memantine extended release, as well as its extent of absorption in pediatric patients with autism.

Study identification

NCT ID
NCT00872898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
124 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
6 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Jul 31, 2012
Completion
Not listed
Last update posted
Jan 13, 2014

Started 2009

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Forest Investigative Site Phoenix Arizona 85006
Forest Investigative Site Sacramento California 95817
Forest Investigative Site San Francisco California 94143
Forest Investigative Site Santa Ana California 92705
Forest Investigative Site Stanford California 94305
Forest Investigative Site Jacksonville Beach Florida 32250
Forest Investigative Site St. Petersburg Florida 33701
Forest Investigative Site Hoffman Estates Illinois 60169
Forest Investigative site Naperville Illinois 60563
Forest Investigative Site Indianapolis Indiana 46202
Forest Investigative Site Cambridge Massachusetts 02138
Forest Investigative Site Toms River New Jersey 08755
Forest Investigative Site Voorhees Township New Jersey 08043
Forest Investigative Site Manhasset New York 11030
Forest Investigative Site Cleveland Ohio 44106
Forest Investigative Site Columbus Ohio 43210
Forest Investigative Site Oklahoma City Oklahoma 73116

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Autism trials

Other public records listing Autism. Sorted by last update posted; newest first. Not a recommendation.

All Autism trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00872898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2014 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00872898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →